ArticleImmunologic research2026
Memory-biased CD8αα⁺ T cells show reduced abundance and phenotypic remodeling in SLE.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To characterize peripheral CD8αα⁺ T cells in systemic lupus erythematosus (SLE), evaluate their quantitative and phenotypic alterations, and examine associations with autoantibody profiles and inflammatory markers. Forty treatment-naïve SLE patients and 46 age- and sex-matched healthy controls were recruited. Peripheral blood mononuclear cells were analyzed by flow cytometry to quantify CD8αα⁺ and CD8αβ⁺ T-cell subsets, differentiation states (TN, TCM, TEM, TEMRA), and expression of CCR7, CD45RA, CD28, CD27, GZMB, perforin, and GPR56. Correlations with autoantibodies, immunoglobulin levels, complement, and inflammatory markers were assessed. In healthy controls, CD8αα⁺ T cells were less abundant than CD8αβ⁺ T cells and predominantly enriched in central memory (TCM) and terminally differentiated effector memory RA⁺ (TEMRA) subsets, with lower CD28, CD27, CCR7, and GZMB expression. In SLE patients, CD8αα⁺ T cells showed further reductions in absolute counts, decreased CD28, and increased GZMB and GPR56, while differentiation subset distribution remained unchanged. Alterations in CD8αα⁺ T-cell counts and marker expression correlated with autoantibody titers, immunoglobulin levels, complement C4, and inflammatory indices. Peripheral CD8αα⁺ T cells form a distinct memory-enriched subset that is numerically reduced and phenotypically remodeled in SLE. Their quantitative and phenotypic alterations correlate with immunological and inflammatory parameters.
Indexed as
Identifiers
41801506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.